Teachers Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Teachers Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$327K	Buy	+1,242	New	+$214K	﹤0.01%	2687

Other funds holding DNTH

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Teachers Advisors's DNTH Position: Q1 2019 in Review

Teachers Advisors opened a new position in Dianthus Therapeutics (DNTH) in Q1 2019: 1,242 shares worth $327K. The stake represents ﹤0.01% of the portfolio and ranks #2687 among its holdings.

63 funds tracked by Wall St. Rank hold DNTH as of Q1 2019.

Teachers Advisors held 1,242 shares of Dianthus Therapeutics worth $327K as of Q1 2019.
Dianthus Therapeutics was a new Teachers Advisors position in Q1 2019.
Dianthus Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2687 holding.
63 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.